Suchergebnisse - "Lê, Minh P"

PubPharm (27)

1

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study)

enthalten in: British journal of clinical pharmacology | 2024

von Lemaitre, F. | Lagoutte-Renosi, J. | Gagnieu, M. | +61

2

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study)

enthalten in: British Journal of Clinical Pharmacology | 2024

von Lemaitre, F. | Lagoutte‐Renosi, J. | Gagnieu, M. | +10

3

Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity

enthalten in: Journal of clinical immunology | 2023

von César, T. | Le, M. | Klifa, R. | +12

4

Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity

enthalten in: Journal of clinical immunology | 2023

von César, T. | Le, M. | Klifa, R. | +12

5

Dabigatran-reversal failure using standard dose of idarucizumab : a systematic review and meta-analysis of cases

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Melicine, S. | Billoir, P. | Faille, D. | +5

6

Doravirine Exposure Decreased by Dialysis in a HIV Patient : A Grand Round

enthalten in: Therapeutic drug monitoring | 2023

von Fromage, Y. | Codde, C. | Monchaud, C. | +4

7

Pharmaco-virological algorithm to target risk of drug resistance among a population of HIV-infected key populations in Togo

enthalten in: Journal of medical virology | 2023

von Ferré, V. | Bitty-Anderson, A. | Peytavin, G. | +7

8

Pharmaco‐virological algorithm to target risk of drug resistance among a population of HIV‐infected key populations in Togo

enthalten in: Journal of Medical Virology | 2023

von Ferré, V. | Bitty‐Anderson, A. | Peytavin, G. | +7

9

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi : a prospective cohort study

enthalten in: The lancet. HIV | 2022

von Schramm, B. | Temfack, E. | Descamps, D. | +12

CommentIn: Lancet HIV. 2022 Aug;9(8):e523-e524. - PMID 35905750

10

HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection

enthalten in: The Journal of infectious diseases | 2022

von Ghosn, J. | Assoumou, L. | Lascoux-Combe, C. | +9